Trial intelligence / Profile preview

Propranolol reconsolidation intervention for traumatized healthcare workers with PTSD

NL-OMON49882Withdrawn

Sponsor
TNO
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by TNO. Planned start Aug 2020; status: withdrawn.

02

Drugs

propranolol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NL-OMON49882.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON49882.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call